<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.4: PCOS: Phenotypes and Management Strategies</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PINK/PURPLE theme for Female Hormones */
        .module-header {
            background: linear-gradient(135deg, #9d174d 0%, #db2777 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #9d174d;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #9d174d;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #9d174d;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fdf2f8;
            border: 2px solid #db2777;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #9d174d;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #fdf2f8 0%, #fce7f3 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #f9a8d4;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #9d174d;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #db2777;
        }

        .term-item .term {
            font-weight: 700;
            color: #9d174d;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #9d174d;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #fbcfe8 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #fff1f2 0%, #fff5f7 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #fecdd3;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #9d174d;
            font-weight: 600;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #9d174d 0%, #db2777 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #fdf2f8 0%, #fce7f3 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #9d174d 0%, #db2777 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Principle Cards */
        .principle-card {
            background: white;
            border-left: 5px solid #db2777;
            padding: 24px 28px;
            margin-bottom: 18px;
            border-radius: 0 14px 14px 0;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.04);
        }

        .principle-card .principle-title {
            font-weight: 700;
            color: #9d174d;
            margin: 0 0 10px 0;
            font-size: 17px;
        }

        /* Data Table */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #fce7f3;
            color: #9d174d;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #f9a8d4;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            color: #4b5563;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fffaf0;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #9d174d;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #fdf2f8;
            border-radius: 8px;
            margin-top: 10px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #9d174d;
            margin-bottom: 15px;
            text-transform: uppercase;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding-top: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 8px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Female Sex Hormones & Infradian Rhythms</p>
            <h1 class="lesson-title">Lesson 8.4: PCOS: Phenotypes and Management Strategies</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Redefining PCOS</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Rotterdam Phenotypes</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Root Cause Drivers</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The SIGNAL Methodâ„¢ for PCOS</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Nutritional Precision</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Infradian Alignment</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between the four clinical phenotypes of PCOS based on the Rotterdam Criteria.</li>
                <li>Identify the primary physiological drivers of PCOS, including insulin resistance and chronic inflammation.</li>
                <li>Apply the SIGNAL Methodâ„¢ to create bio-individual management strategies for clients.</li>
                <li>Analyze the role of the infradian rhythm in managing ovulatory dysfunction.</li>
                <li>Select evidence-based micronutrients and botanicals for androgen regulation.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Complexity of PCOS</h3>
            <p>Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, yet it remains one of the most misunderstood. It is not a "one-size-fits-all" condition. As a Hormone Health Coach, your goal is to move beyond the nameâ€”which is arguably a misnomer, as many women with PCOS do not have "cysts"â€”and identify the specific <span class="highlight">metabolic and hormonal phenotype</span> your client presents with.</p>
        </div>

        <h2 id="section1">Redefining PCOS: More Than Ovarian Cysts</h2>
        <p>PCOS is a heterogenous clinical syndrome characterized by <span class="highlight">hyperandrogenism</span>, ovulatory dysfunction, and metabolic disturbances. The name is misleading because the "cysts" seen on ultrasound are actually immature follicles that failed to release an egg due to hormonal imbalances, not pathological cysts. A 2023 meta-analysis (n=12,450) confirmed that PCOS affects approximately <span class="highlight">8% to 13%</span> of reproductive-aged women globally, with up to 70% of cases remaining undiagnosed.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">4x</div>
                    <div class="stat-label">Higher Risk of Type 2 Diabetes</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">75%</div>
                    <div class="stat-label">Have Insulin Resistance</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Experience Anxiety/Depression</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">80%</div>
                    <div class="stat-label">Of Anovulatory Infertility</div>
                </div>
            </div>
        </div>

        <h2 id="section2">The Rotterdam Phenotypes</h2>
        <p>To provide professional-level coaching, you must understand the <span class="highlight">Rotterdam Criteria</span>, which requires at least two of the following three: 1) Oligo- or anovulation, 2) Clinical or biochemical hyperandrogenism, and 3) Polycystic ovaries on ultrasound. This creates four distinct phenotypes that dictate the management strategy.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Phenotype</th>
                        <th>Clinical Features</th>
                        <th>Metabolic Profile</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Type A (Classic)</strong></td>
                        <td>Hyperandrogenism + Anovulation + PCO</td>
                        <td>Highest risk for insulin resistance and metabolic syndrome.</td>
                    </tr>
                    <tr>
                        <td><strong>Type B (Hyperandrogenic)</strong></td>
                        <td>Hyperandrogenism + Anovulation</td>
                        <td>Severe hormonal imbalance; high risk for CVD and diabetes.</td>
                    </tr>
                    <tr>
                        <td><strong>Type C (Ovulatory)</strong></td>
                        <td>Hyperandrogenism + PCO</td>
                        <td>"Hidden" PCOS; normal cycles but high androgens and hirsutism.</td>
                    </tr>
                    <tr>
                        <td><strong>Type D (Non-Androgenic)</strong></td>
                        <td>Anovulation + PCO</td>
                        <td>Lean PCOS common; lower androgens but significant ovulatory issues.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Hyperandrogenism</p>
                    <p class="definition">Excessive levels of androgens (like testosterone or DHEA-S) leading to hirsutism, acne, or male-pattern hair loss.</p>
                </div>
                <div class="term-item">
                    <p class="term">Hirsutism</p>
                    <p class="definition">Excessive growth of dark or coarse hair in a male-like pattern (face, chest, back) in women.</p>
                </div>
                <div class="term-item">
                    <p class="term">SHBG</p>
                    <p class="definition">Sex Hormone Binding Globulin; when low, more free testosterone is available to cause symptoms.</p>
                </div>
            </div>
        </div>

        <h2 id="section3">Root Cause Drivers</h2>
        <p>While the phenotypes describe the symptoms, the <span class="highlight">Identify Root Dysfunctions</span> (the 'I' in SIGNAL) step focuses on the underlying drivers. These typically fall into four categories:</p>

        <div class="principle-card">
            <p class="principle-title">1. Insulin Resistance (The Metabolic Driver)</p>
            <p class="principle-text">Insulin acts as a co-gonadotropin. High insulin levels signal the ovaries' theca cells to produce more testosterone and simultaneously lower SHBG levels in the liver. This accounts for ~70-80% of PCOS cases.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">2. Chronic Low-Grade Inflammation</p>
            <p class="principle-text">Inflammation from gut dysbiosis, environmental toxins, or poor diet can stimulate theca cells to produce androgens and worsen insulin resistance. High hs-CRP is a common biomarker here.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">3. Adrenal Hyperandrogenism</p>
            <p class="principle-text">In about 20-30% of women with PCOS, the excess androgens come primarily from the adrenal glands (DHEA-S) rather than the ovaries, often driven by a hypersensitive HPA-axis.</p>
        </div>

        <h2 id="section4">The SIGNAL Methodâ„¢ for PCOS Management</h2>
        <p>We apply the SIGNAL Methodâ„¢ to create a comprehensive roadmap for the client:</p>

        <p><strong>Survey & Systematize:</strong> We begin by tracking cycle length and basal body temperature (BBT) to confirm ovulation. We also look at laboratory data: Fasting Insulin, HbA1c, DHEA-S, Total/Free Testosterone, and LH:FSH ratio (often 2:1 or 3:1 in PCOS).</p>

        <p><strong>Identify Root Dysfunctions:</strong> Is the client's PCOS driven by insulin, inflammation, or the adrenals? A client with normal insulin but high hs-CRP requires a different protocol than one with metabolic syndrome.</p>

        <p><strong>Glandular Support:</strong> We support the ovaries and adrenals. Botanicals like <span class="highlight">Spearmint tea</span> (anti-androgenic) and <span class="highlight">Saw Palmetto</span> (5-alpha reductase inhibitor) can be helpful for hirsutism.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Lean PCOS (Phenotype D)</p>
                    <p style="color: white; margin: 0; font-size: 13px;">Client: Sarah, 28 | Goal: Regularize Cycles</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Presentation:</strong> Sarah presented with "lean PCOS." BMI of 21, clear skin, but cycles lasting 45-60 days. Ultrasound showed polycystic ovaries. Lab work showed normal fasting insulin (5 Î¼IU/mL) but high LH:FSH ratio (3:1).</p>
                <p><strong>Intervention:</strong> Instead of a low-carb diet (which could stress her adrenals), we focused on <strong>Alignment of Rhythms</strong>. We utilized Myo-inositol (4g/day) to improve oocyte quality and implemented a "Pro-Metabolic" approach with adequate complex carbohydrates to lower cortisol-driven androgen production.</p>
                <p><strong>Outcome:</strong> After 4 months, Sarah's cycles shortened to 32 days, and BBT tracking confirmed ovulation for three consecutive months.</p>
            </div>
        </div>

        <h2 id="section5">Nutritional Precision for PCOS</h2>
        <p>Nutritional precision is the cornerstone of PCOS management. The goal is to <span class="highlight">blunt the glucose-insulin response</span> while providing the building blocks for hormone synthesis. A 2022 study published in <i>Nutrients</i> found that a Mediterranean-style diet reduced androgen levels by 15-20% in women with PCOS over 12 weeks.</p>

        <div class="principle-card">
            <p class="principle-title">The "PCOS Plate" Strategy</p>
            <ul class="content-list">
                <li><strong>Protein First:</strong> 25-30g per meal to stimulate glucagon and stabilize blood sugar.</li>
                <li><strong>Fiber Focus:</strong> 35g+ daily to assist in the excretion of metabolized androgens.</li>
                <li><strong>Strategic Fats:</strong> Omega-3 fatty acids (EPA/DHA) to reduce follicular inflammation.</li>
                <li><strong>Inositol Supplementation:</strong> A 40:1 ratio of Myo-inositol to D-chiro-inositol has been shown in clinical trials to be as effective as Metformin for improving insulin sensitivity with fewer side effects.</li>
            </ul>
        </div>

        <h2 id="section6">Infradian Alignment: Working With the Rhythm</h2>
        <p>Women with PCOS often have a "stalled" infradian rhythm. In the follicular phase, high androgens or insulin may prevent the dominant follicle from maturing, leading to a long or non-existent luteal phase. Alignment involves:</p>

        <p><strong>1. Movement Synchronization:</strong> High-intensity interval training (HIIT) can be beneficial for insulin-resistant phenotypes but may worsen adrenal-driven PCOS. Strength training is the "gold standard" for all PCOS types as it increases non-insulin dependent glucose uptake in the muscles.</p>

        <p><strong>2. Light Exposure:</strong> Morning sunlight (within 30 minutes of waking) helps regulate the master circadian clock, which in turn influences the LH pulse frequency. This is vital for clients with high LH levels that prevent ovulation.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of PCOS phenotypes and management.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Which PCOS phenotype is characterized by hyperandrogenism and polycystic ovaries but features regular ovulatory cycles?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Phenotype C (Ovulatory PCOS). These clients often struggle with skin and hair issues but may not realize they have PCOS until an ultrasound is performed.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Why is fasting insulin a more critical biomarker than HbA1c for most PCOS clients?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">HbA1c measures average blood sugar over 3 months, but insulin resistance can be present for a decade before blood sugar rises. Fasting insulin reveals the "effort" the body is making to keep blood sugar normal, which is the primary driver of ovarian androgen production.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>PCOS is a spectrum; always identify the phenotype (A, B, C, or D) before creating a protocol.</li>
                <li>Insulin resistance is the primary driver in ~75% of cases, making glucose management the first line of defense.</li>
                <li>The SIGNAL Methodâ„¢ ensures we look at root causes (Inflammation, Adrenals, Gut) rather than just suppressing symptoms.</li>
                <li>Strength training and Inositol (40:1 ratio) are among the most evidence-based interventions for restoring ovulation.</li>
                <li>Alignment of infradian rhythms through light and movement is essential for regulating the LH:FSH balance.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Teede, H. J., et al. (2023). "Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome." <i>The Lancet Diabetes & Endocrinology.</i></li>
                <li>Barber, T. M., et al. (2021). "The Link Between Polycystic Ovary Syndrome and Insulin Resistance: An Update." <i>Frontiers in Endocrinology.</i></li>
                <li>Lizneva, D., et al. (2016). "Phenotypes and Genotypes of Polycystic Ovary Syndrome." <i>Fertility and Sterility.</i></li>
                <li>Gleicher, N., et al. (2022). "A Review of the World Health Organization and Rotterdam Criteria for PCOS." <i>Journal of Assisted Reproduction and Genetics.</i></li>
                <li>Nordio, M., et al. (2019). "The 40:1 Myo-inositol/D-chiro-inositol Ratio in the Treatment of PCOS: An Update." <i>European Review for Medical and Pharmacological Sciences.</i></li>
                <li>Armanini, D., et al. (2014). "Spearmint Tea Has Anti-androgen Effects in PCOS." <i>Phytotherapy Research.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Hormone Health Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>